Could HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?
about
Could HBx protein expression affect signal pathway inhibition by gefitinib or selumetinib, a MEK inhibitor, in hepatocellular carcinoma cell lines?
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Could HBx protein expression a ...... cellular carcinoma cell lines?
@ast
Could HBx protein expression a ...... cellular carcinoma cell lines?
@en
Could HBx protein expression a ...... cellular carcinoma cell lines?
@nl
type
label
Could HBx protein expression a ...... cellular carcinoma cell lines?
@ast
Could HBx protein expression a ...... cellular carcinoma cell lines?
@en
Could HBx protein expression a ...... cellular carcinoma cell lines?
@nl
prefLabel
Could HBx protein expression a ...... cellular carcinoma cell lines?
@ast
Could HBx protein expression a ...... cellular carcinoma cell lines?
@en
Could HBx protein expression a ...... cellular carcinoma cell lines?
@nl
P2093
P2860
P1476
Could HBx protein expression a ...... cellular carcinoma cell lines?
@en
P2093
Dong Jin Suh
Han Chu Lee
Kang Mo Kim
Ki-Hun Kim
Sung-Gyu Lee
Yoon Kyung Park
Young-Hwa Chung
Young-Joo Lee
Young-Suk Lim
P2860
P304
P356
10.3346/JKMS.2011.26.2.214
P50
P577
2011-01-24T00:00:00Z